Search Results - "GAVASSO, S."

Increased anticoagulant response to low‐molecular‐weight heparin in plasma from patients with advanced cirrhosis by SENZOLO, M., RODRIGUEZ‐Castro, K. I., ROSSETTO, V., RADU, C., GAVASSO, S., CARRARO, P., ZERBINATI, P., SARTORI, M. T., SIMIONI, P.

“…Introduction:  Cirrhotic patients may present thrombotic complications that warrant anticoagulant therapy. However, the efficacy of low‐molecular‐weight…”
Get full text

“In vitro” correction of the severe factor V deficiency‐related coagulopathy by a novel plasma‐derived factor V concentrate by Bulato, C., Novembrino, C., Anzoletti, M. Boscolo, Spiezia, L., Gavasso, S., Berbenni, C., Tagariello, G., Farina, C., Nardini, I., Campello, E., Peyvandi, F., Simioni, P.

“…Introduction Severe congenital factor V (FV) deficiency is a rare bleeding disorder characterized by very low/undetectable levels of FV. Fresh frozen plasma is…”
Get full text

Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories by Bader, L. I., Solberg, S. M., Kaada, S. H., Bolstad, N., Warren, D. J., Gavasso, S., Gjesdal, C. G., Vedeler, C. A.

“…Immunogenicity is a frequent cause of secondary non‐response to tumour necrosis factor (TNF) inhibitors. Drug level measurement and detection of antidrug…”
Get full text

The haemostatic system in acromegaly: a single-centre case–control study by Campello, E., Marobin, M., Barbot, M., Radu, C. M., Voltan, G., Spiezia, L., Gavasso, S., Ceccato, F., Scaroni, C., Simioni, P.

“…Purpose Although the mortality from acromegaly is due in most cases to an increased cardiovascular risk, no study has globally evaluated the haemostatic…”
Get full text

Phosphorylation of intracellular signalling molecules in peripheral blood cells from patients with psoriasis on originator or biosimilar infliximab by Aarebrot, A.K., Solberg, S.M., Davies, R., Bader, L.I., Holmes, T.D., Gavasso, S., Bryceson, Y.T., Jonsson, R., Sandvik, L.F., Appel, S.

“…Summary Background Psoriasis vulgaris is a chronic, inflammatory skin disease characterized by a dysregulated immune response and it is associated with…”
Get full text

Phospho flow cytometry of PBMCs in psoriasis by Aarebrot, A.K., Solberg, S.M., Davies, R., Bader, L.I., Holmes, T.D., Gavasso, S., Bryceson, Y.T., Jonsson, R., Sandvik, L.F., Appel, S.

“…Summary Psoriasis is a chronic inflammatory skin disease, which affects approximately 2% of the population. Severe psoriasis is often treated by inhibition of…”
Get full text

Hyperfibrinolysis during liver transplantation detected by classical parameters and thromboelastometry by Maggiolo, S, Campello, E, Spiezia, L, Tredese, A, Saggiorato, G, Gavasso, S, Feltracco, P, Simioni, P

Get full text

Whole Blood Coagulation Tests are not Equally able to Detect Haemostatic Prothrombotic Alterations in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Rotational Thromboelastometry versus Thrombingeneration Test by Zanetto, A, Ferrarese, A, Nadal, E, Bortoluzzi, I, Campello, E, Spiezia, L, Cillo, U, Vitale, A, Farinati, F, Germani, G, Russo, F.P, Gavasso, S, Simioni, P, Burra, P, Senzolo, M

Get full text

Genetic modulation of the FVLeiden/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes by SEGERS, O., SIMIONI, P., TORMENE, D., BULATO, C., GAVASSO, S., ROSING, J., CASTOLDI, E.

“…Background and Objectives: The factor (F) V Leiden mutation causes activated protein C (APC) resistance by decreasing the susceptibility of FVa to APC‐mediated…”
Get full text

Local prothrombotic state in portal venous system in cirrhosis by Shalaby, S, Simioni, P, Campello, E, Gavasso, S, Zanetto, A, D’Amico, F, Gringeri, E, Cillo, U, Battistel, M, Burra, P, Senzolo, M

Get full text

Thrombin generation in Cushing’s Syndrome: do the conventional clotting indices tell the whole truth? by Koutroumpi, S., Spiezia, L., Albiger, N., Barbot, M., Bon, M., Maggiolo, S., Gavasso, S., Simioni, P., Frigo, A., Mantero, F., Scaroni, C.

“…Cushing’s Syndrome (CS) is associated with an increased mortality, where hypercoagulability seems to have a crucial role in both arterial and venous…”
Get full text

Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia by CASTOLDI, E., SIMIONI, P., TORMENE, D., THOMASSEN, M. C. L. G. D., SPIEZIA, L., GAVASSO, S., ROSING, J.

“…Background: Hyperprothrombinemia, resulting from the prothrombin G20210A mutation or other causes, is associated with activated protein C (APC) resistance and…”
Get full text

Thrombin Activatable Fibrinolysis inhibitor in Cancer Patients with and without Venous Thromboembolism by Radu, C.M, Spiezia, L, Campello, E, Gavasso, S, Woodhams, B, Simioni, P

Get full text

O32 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC ALTERATIONS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA by Zanetto, A, Ferrarese, A, Vitale, A, Cillo, U, Rodriguez, K.-I, Fadin, M, Gavasso, S, Radu, C, Zerbinati, P, Simioni, P, Farinati, F, Germani, G, Russo, F.P, Burra, P, Senzolo, M

Get full text

Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis by Gavasso, S, Gjertsen, BT, Anderssen, E, Myhr, KM, Vedeler, C

“…Background: Immunogenicity of recombinant interferon-β (IFN-β) is a known complication in the therapy of relapsing–remitting multiple sclerosis (RRMS)…”
Get full text

Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis by Rossetto, V., Spiezia, L., Senzolo, M., Rodriguez, K., Gavasso, S., Woodhams, B., Simioni, P.

“…Summary Introduction Portal vein thrombosis (PVT) is caused by local and systemic prothrombotic risk factors. In this case‐control study, we evaluated the use…”
Get full text

235 PREDICTORS OF RESPONSE TO ANTICOAGULANT THERAPY FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS (PVT) IN CIRRHOSIS PATIENTS by Rodríguez-Castro, K.I, Sartori, M.T, Radu, C.M, Gavasso, S, Zerbinati, P, Bortoluzzi, I, Nadal, E, Simioni, P, Burra, P, Senzolo, M

Get full text

Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis by Spiezia, L, Campello, E, Bon, M, Gavasso, S, Woodhams, B, Simioni, P

Get full text

Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) by Zanetto, A, Ferrarese, A, Rodriguez, K, Fadin, M, Gavasso, S, Radu, C, Zerbinati, P, Vitale, A, Cillo, U, Farinati, F, Russo, F.P, Germani, G, Simioni, P, Burra, P, Senzolo, M

Get full text

PBMC磷酸流式细胞术治疗银屑病 by Aarebrot, A.K., Solberg, S.M., Davies, R., Bader, L.I., Holmes, T.D., Gavasso, S., Bryceson, Y.T., Jonsson, R., Sandvik, L.F., Appel, S.

“…Summary…”
Get full text